| Joseph C Jameson, MD | |
|
1414 W Fair Avenue, Suite 230, Marquette, MI 49855-2675 | |
| (906) 225-3853 | |
| (906) 228-4065 |
| Full Name | Joseph C Jameson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 39 Years |
| Location | 1414 W Fair Avenue, Marquette, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619974060 | NPI | - | NPPES |
| 0E26017 | Other | MI | BLUE CROSS/BLUE SHIELD |
| 2917294 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | JJ057538 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Healthcare Grayling Hospital | Grayling, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Healthcare Grayling | 2062736655 | 55 |
News Archive
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today provided an update on preliminary sales for October and November 2010.
Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of a temporary tattoo.
› Verified 3 days ago
| Entity Name | Munson Healthcare Otsego Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164628426 PECOS PAC ID: 8325942535 Enrollment ID: O20040305000525 |
News Archive
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today provided an update on preliminary sales for October and November 2010.
Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of a temporary tattoo.
› Verified 3 days ago
| Entity Name | Munson Healthcare Grayling |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710383351 PECOS PAC ID: 2062736655 Enrollment ID: O20150326000110 |
News Archive
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today provided an update on preliminary sales for October and November 2010.
Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of a temporary tattoo.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph C Jameson, MD 1414 W Fair Avenue, Suite 230, Marquette, MI 49855-2675 Ph: (906) 225-3853 | Joseph C Jameson, MD 1414 W Fair Avenue, Suite 230, Marquette, MI 49855-2675 Ph: (906) 225-3853 |
News Archive
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today provided an update on preliminary sales for October and November 2010.
Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of a temporary tattoo.
› Verified 3 days ago
Patrick P Bulinski, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1414 W. Fair Avenue, Suite 230, Marquette, MI 49855 Phone: 906-225-3853 Fax: 906-228-4065 | |
Ryan D. Edwards, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1414 W. Fair Avenue, Suite 230, Marquette, MI 49855 Phone: 906-225-3853 Fax: 906-228-4065 | |
Andrew G Swentik, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1414 W Fair Ave Ste 190, Marquette, MI 49855 Phone: 906-225-1321 Fax: 906-228-9371 | |
Dr. Frank Farbod, M.d., D.m.d, MD,DMD, FACS, FRCS Surgery Medicare: Not Enrolled in Medicare Practice Location: 1029 Lincoln Ave Ste 4, Suite 4, Marquette, MI 49855 Phone: 906-225-5959 | |
Dr. Alan F Hunter, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 420 W Magnetic St, Suite Er, Marquette, MI 49855 Phone: 888-674-0854 Fax: 906-225-3370 | |
Larry S Lewis, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1414 W Fair Avenue, Suite 230, Marquette, MI 49855 Phone: 906-225-3853 Fax: 906-228-4065 |